JAGUAR HEALTH, INC. (JAGX) Return on equity 2017–2024
JAGUAR HEALTH, INC. (JAGX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-592.7%FY2024 · since FY2017: -127.3% → -592.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -592.7% | -591.9 pp |
| FY2023 | -0.9% | — |
| FY2021 | -0.4% | +196.1 pp |
| FY2020 | -196.5% | +164.5 pp |
| FY2019 | -361.1% | +236.1 pp |
| FY2018 | -597.2% | -469.9 pp |
| FY2017 | -127.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice